Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

This report provides a complete quantitative data and qualitative analysis on the global market for Colorectal Cancer Therapeutics. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Colorectal Cancer Therapeutics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Colorectal Cancer Therapeutics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Colorectal Cancer Therapeutics, including the following market information:
Global Colorectal Cancer Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Colorectal Cancer Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Colorectal Cancer Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Colorectal Cancer Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Diagnostics
Therapeutics

Based on the Application:
Hospitals
Clinic
Research institutions